Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Number of holders
-
319
-
Total 13F shares, excl. options
-
144,555,723
-
Shares change
-
-3,950,657
-
Total reported value, excl. options
-
$8,993,046,726
-
Value change
-
-$244,244,682
-
Put/Call ratio
-
76.12%
-
Number of buys
-
162
-
Number of sells
-
-139
-
Price
-
$62.21
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q2 2014
386 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q2 2014.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 319 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 144,555,723 shares
of 193,539,047 outstanding shares and own 74.69% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (17,876,013 shares), SANDS CAPITAL MANAGEMENT, LLC (11,925,248 shares), FMR LLC (9,218,017 shares), VANGUARD GROUP INC (8,226,701 shares), PRIMECAP MANAGEMENT CO/CA/ (8,064,219 shares), JENNISON ASSOCIATES LLC (5,347,735 shares), State Street Corp (4,318,081 shares), BlackRock Institutional Trust Company, N.A. (3,521,596 shares), WELLS FARGO & COMPANY/MN (2,920,405 shares), and BlackRock Fund Advisors (2,834,388 shares).
This table shows the top 319 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.